From leading-edge healthcare to improved environments, life science and biotech companies encompass a broad spectrum of innovative fields that advance the quality of our lives. The organisations built to move science-based discoveries forward can be structured around critical developments such as the convergence of drugs and devices, advances in breakthrough targeted therapies, and novel collaborations to uncover and commercialise new technologies.
The challenges facing these companies range from securing funding, navigating the regulatory environment, collaborating with partners and communicating value and differentiation. Regardless of the challenge, Edelman helps life science-based industries navigate them to achieve their business objectives.
We structure science stories around brands to shape communications strategy. Known as science engagement, this process informs the creation of communications strategies shaped to fit our clients’ business model, philosophy, market drivers and portfolio. In an era of transformational scientific advances, this translation is critical for engagement with publics, and ultimately product acceptance. Our team activates communication strategies including scientific narratives and visualisations, expert engagement, market access initiatives and media positioning.
Our key capabilities for life sciences and biotech clients include:
- The Science Narrative model, which involves synthesizing the thinking of key influencers, rooted in science, to inform the story of our client’s brand/company.
- Stakeholder perception mapping, developed through research of experts to engage, inform and build support.
- Media strategy and channels to optimise public engagement and understanding of our client’s brand/company, aligned with product strategy, positioning and execution in response to changing reimbursement structures to address market access.